Other languages Shield Therapeutics plc

Equities

Delayed London S.E. Other stock markets 15:15:34 01/05/2024 BST			5-day change	1st Jan Change
1.67 ^GBX	+23.70%		+17.19%	-75.07%

04-30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
02-22	Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024

FTSE 100 takes hit ahead of FOMC minutes	02-21
Shield Therapeutics sinks as strong performance marred by data issues	02-21
Shield Therapeutics hires former Akili leader as new CFO	01-09
Shield Therapeutics Names New CFO	01-09
Comptoir opens restaurant; Intercede wins contract	12-07
Shield Therapeutics Chief Financial Officer Rudolf to leave	12/10/23
AIM WINNERS & LOSERS: Windward sees high contracting activity levels	12/10/23
Shield Therapeutics CFO to Step Down	12/10/23
Aston Martin CEO ups stake; Alkemy's lithium deal	03/10/23
Shield Therapeutics completes USD20 million SWK financing	03/10/23
Shield Therapeutics Closes $20 Million Debt Facility with SWK Funding	03/10/23
EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy	02/10/23
Shield Therapeutics Raises $6 Million via Share Issue	29/09/23
Shield Therapeutics completes GBP5 million share placing	28/09/23
Shield Therapeutics raises funds for US sales push as loss narrows	28/09/23
Earnings Flash (STX.L) SHIELD THERAPEUTICS Posts H1 Revenue $4.3M	28/09/23
Shield Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023	28/09/23
Shield Therapeutics changes reporting currency to US dollars	06/09/23
Shield Therapeutics prescription orders up in first quarter	20/07/23
Shield Therapeutics plc Auditor Raises 'Going Concern' Doubt	18/05/23

No results for this search